UAB Digital Repository of Documents 2 records found  Search took 0.01 seconds. 
1.
11 p, 963.8 KB MiRNA profiling of whole trabecular bone : identification of osteoporosis-related changes in MiRNAs in human hip bones / De-Ugarte, Laura (Institut Hospital del Mar d'Investigacions Mèdiques) ; Yoskovitz, Guy (Institut Hospital del Mar d'Investigacions Mèdiques) ; Balcells, Susana (Departament de Genètica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Universitat de Barcelona, IBUB, Barcelona, Spain) ; Güerri-Fernández, Robert (Hospital del Mar. Departament de Medicina Interna) ; Martinez-Diaz, Santos (Hospital del Mar. Departament de Cirurgia Ortopèdica i TGraumatologia) ; Mellibovsky, Leonardo (Hospital del Mar. Departament de Medicina Interna) ; Urreizti, Roser (Departament de Genètica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Universitat de Barcelona, IBUB, Barcelona, Spain) ; Nogués, Xavier (Hospital del Mar. Departament de Medicina Interna) ; Grinberg, Daniel (Departament de Genètica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Universitat de Barcelona, IBUB, Barcelona, Spain) ; García-Giralt, Natalia (Institut Hospital del Mar d'Investigacions Mèdiques) ; Díez-Pérez, Adolfo (Hospital del Mar. Departament de Medicina Interna) ; Universitat Autònoma de Barcelona
MicroRNAs (miRNAs) are important regulators of gene expression, with documented roles in bone metabolism and osteoporosis, suggesting potential therapeutic targets. Our aim was to identify miRNAs differentially expressed in fractured vs nonfractured bones. [...]
2015 - 10.1186/s12920-015-0149-2
BMC medical genomics, Vol. 8 (november 2015)  
2.
12 p, 915.6 KB PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers / Bastien, Roy R. L. (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Rodríguez-Lescure, Álvaro (Hospital Universitario de Elche (Elx, País Valencià)) ; Ebbert, Mark T.W. (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Prat, Aleix (Universitat Autónoma de Barcelona. Departament de Medicina) ; Munárriz, Blanca (Hospital Universitario La Fe (València, País Valencià)) ; Rowe, Leslie (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Miller, Patricia (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Ruiz Borrego, Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Anderson, Daniel (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Lyons, Bradley (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Álvarez, Isabel (Hospital de Donostia (Sant Sebastià, País Basc)) ; Dowell, Tracy (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Wall, David (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Seguí, Miguel Ángel (Corporatiò Sanitaria Parc Taulí (Sabadell, Catalunya)) ; Barley, Lee (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Boucher, Kenneth M. (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ; Alba, Emilio (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Pappas, Lisa (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ; Davis, Carole A. (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ; Aranda, Ignacio (Hospital General Universitario de Alicante (Alacant, País Valencià)) ; Fauron, Christiane (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Stijleman, Inge J. (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ; Palacios, José (Hospital Virgen del Rocio (Sevilla, Andalusia)) ; Antón, Antonio (Hospital Universitario Miguel Servet (Saragossa, Aragó)) ; Carrasco, Eva (GEICAM. Spanish Breast Cancer Research Group (Madrid)) ; Caballero, Rosalía (GEICAM. Spanish Breast Cancer Research Group (Madrid)) ; Ellis, Matthew J. (Washington University. Department of Oncology (St. Louis, Estats Units d'Amèrica)) ; Nielsen, Torsten O. (University of British Columbia. Department of Anatomical Pathology (Vancouver, Canadà)) ; Perou, Charles M. (University of North Carolina at Chapel Hill. Lineberger Comprehensive Cancer Center (Chapel Hill, Estats Units d'Amèrica)) ; Astill, Mark (The ARUP Institute for Clinical and Experimental Pathology (Salt Lake City, Estats Units d'Amèrica)) ; Bernard, Philip S. (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ; Martín, Miguel (Universidad Complutense de Madrid. Hospital General Universitario Gregorio Marañón)
Background: Many methodologies have been used in research to identify the "intrinsic" subtypes of breast cancer commonly known as Luminal A, Luminal B, HER2-Enriched (HER2-E) and Basal-like. The PAM50 gene set is often used for gene expression-based subtyping; however, surrogate subtyping using panels of immunohistochemical (IHC) markers are still widely used clinically. [...]
2012 - 10.1186/1755-8794-5-44
BMC medical genomics, Vol. 15, N. 44 (October 2012) , p. 1-9
4 documents

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.